Interview case studies - Commercial Law Academy

body { height: 100vh; max-width: 100vw; margin: 0; } #wrap { display: none; } .noscript-container { display: flex; flex-direction: column; justify-content: center; align-items: center; height: 100%; padding: 10px; text-align: center; background-color: #eee; } .noscript-container i { font-size: 50px; } .noscript-container h3 { margin-bottom: 10px; font-weight: 700; font-size: 24px; line-height: 1.2; } .noscript-container p { font-size: 16px; color: #929292; } .noscript-container a { color: #1b9eea; } .noscript-container a.btn, .noscript-container a.btn:visited { padding: 8px 20px; margin-top: 20px; border: 1px solid #929292; border-radius: 3px; font-weight: 700; text-decoration: none; color: inherit; } .noscript-container a.btn:hover { background-color: #e6e6e6; }

The content is here but you need to enable JavaScript to view it.

Please enable JavaScript in your browser settings and reload the page.

Go to Dashboard

- ATTACHMENT: Press release re Krynoxi and Introdisem